Combination of MAL and CADM1 markers for HPV induced invasive cancers and their high-grade precursor lesions
Apr 27, 2016
Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek en Patientenzorg has been awarded US Patent No. 9,315,866, "Combination of MAL and CADM1 markers for HPV induced invasive cancers and their high-grade precursor lesions."
In this webinar, Dr. Fergus Couch from the Mayo Clinic will present data from a large study that used a targeted sequencing panel to determine pancreatic cancer risk associated with inherited mutations in several cancer predisposition genes.
In this two-part webinar, Dr. Elin Gray, from Edith Cowan University, and Ms. Weiwei Zhao, from Kingmed diagnostic, will compare the highly sensitive, multiplexed UltraSEEK technology, on the MassARRAY system, to digital droplet PCR (ddPCR) results on melanoma and non-small cell lung carcinoma samples.